by
Thomas Dworetzky, Contributing Reporter | November 05, 2018
The two are combining the capabilities of Philips Illumeo with adaptive intelligence and Nuance PowerScribe 360 platform to reduce discrepancies and improve radiology reporting, accuracy and standardization.
“Philips is taking the approach of developing adaptive intelligence, in this case with Illumeo, to augment the expertise of the radiologist,” Yair Briman, business leader of health care informatics for Philips, told HCB News. “This direction serves to meet the overall goals of health care. It also serves the stated goals of the ACR’s newly launched Data Science Institute, which will work with industry partners and regulators to define the value of AI and spur its adoption in clinical practice, and improve diagnostic consistency and clinical outcomes.”

Ad Statistics
Times Displayed: 46200
Times Visited: 1302 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
Karen Holzberger, vice president and general manager of diagnostics business with Nuance Healthcare, said the combination will optimize report findings and put in place a workflow that reduces redundant steps, thereby saving time and improving accuracy.
“This is going to be the first of what we believe [will be] thousands and thousands of algorithms coming from industry leaders like Philips, because there’s so much data available,” said Holzberger, adding that, "it’s about the development of AI, accepting AI and putting it into practical workflow for the radiologist to be able to adopt them each and every day.”
Integration of the products is currently underway with releases of specialized, high-volume workflows expected sometime in 2018. The project will initially focus on algorithms for lung cancer treatment but will eventually expand to those in other areas of medicine, such as pulmonary embolisms and liver lesions.
Back to HCB News